Monarch Partners Asset Management LLC cut its stake in shares of Xylem Inc. (NYSE:XYL) by 1.3% during the second quarter, Holdings Channel reports. The firm owned 306,250 shares of the company’s stock after selling 3,985 shares during the period. Xylem accounts for 1.4% of Monarch Partners Asset Management LLC’s investment portfolio, making the stock its 22nd largest position. Monarch Partners Asset Management LLC’s holdings in Xylem were worth $13,674,000 as of its most recent filing with the SEC.
Other hedge funds also recently made changes to their positions in the company. Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its stake in shares of Xylem by 10.8% in the first quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 42,417 shares of the company’s stock valued at $1,735,000 after buying an additional 4,142 shares during the period. Aperio Group LLC boosted its stake in shares of Xylem by 12.1% in the first quarter. Aperio Group LLC now owns 116,622 shares of the company’s stock valued at $4,770,000 after buying an additional 12,566 shares during the period. Nisa Investment Advisors L.L.C. boosted its stake in shares of Xylem by 10.9% in the first quarter. Nisa Investment Advisors L.L.C. now owns 50,771 shares of the company’s stock valued at $2,077,000 after buying an additional 5,000 shares during the period. Virginia Retirement System bought a new stake in shares of Xylem during the first quarter valued at approximately $360,000. Finally, Pacad Investment Ltd. bought a new stake in shares of Xylem during the first quarter valued at approximately $249,000. Hedge funds and other institutional investors own 84.70% of the company’s stock.
Xylem Inc. (NYSE:XYL) traded up 1.22% during midday trading on Friday, reaching $52.45. 1,070,115 shares of the company were exchanged. The stock has a market capitalization of $9.40 billion, a price-to-earnings ratio of 28.00 and a beta of 1.15. Xylem Inc. has a 52-week low of $31.67 and a 52-week high of $52.71. The firm’s 50-day moving average price is $50.64 and its 200 day moving average price is $45.58.
Xylem (NYSE:XYL) last announced its earnings results on Tuesday, August 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.47 by $0.01. The firm earned $932 million during the quarter, compared to analyst estimates of $927.69 million. Xylem had a net margin of 9.22% and a return on equity of 16.41%. Xylem’s revenue was up 1.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.43 EPS. Equities analysts predict that Xylem Inc. will post $2.04 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 21st. Shareholders of record on Wednesday, August 31st were issued a $0.1549 dividend. This represents a $0.62 dividend on an annualized basis and a yield of 1.18%. The ex-dividend date of this dividend was Monday, August 29th. Xylem’s payout ratio is 33.16%.
A number of brokerages have issued reports on XYL. Oppenheimer Holdings Inc. restated an “outperform” rating and set a $52.00 target price (up previously from $46.00) on shares of Xylem in a research report on Monday, June 20th. Zacks Investment Research cut shares of Xylem from a “buy” rating to a “hold” rating in a research report on Friday, July 15th. Barclays PLC lifted their target price on shares of Xylem from $39.00 to $45.00 and gave the stock an “equal weight” rating in a research report on Monday, July 18th. Royal Bank Of Canada lifted their target price on shares of Xylem from $47.00 to $51.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 16th. Finally, RBC Capital Markets set a $51.00 target price on shares of Xylem and gave the stock a “buy” rating in a research report on Tuesday, August 16th. Nine investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $45.00.
In other Xylem news, insider Tomas Brannemo sold 8,524 shares of the company’s stock in a transaction dated Wednesday, August 17th. The shares were sold at an average price of $50.06, for a total value of $426,711.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Colin R. Sabol sold 27,473 shares of the company’s stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $50.91, for a total transaction of $1,398,650.43. Following the completion of the sale, the insider now directly owns 65,530 shares of the company’s stock, valued at $3,336,132.30. The disclosure for this sale can be found here. 0.77% of the stock is currently owned by company insiders.
Xylem Company Profile
Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.